Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer Prognosis
Sentinel lymph node biopsy may raise threshold for adjuvant therapy
May 13th, 2004
Sentinel lymph node biopsy may raise the threshold for systemic adjuvant therapy for breast cancer. "Sentinel lymph node (SLN) biopsy is a new standard of care for axillary node staging in breast cancer, which for the first time allows enhanced pathologic analysis on a routine basis. Although a number of retrospective studies, including our own series with 20-year follow-up, suggest that axillary nodal micrometastases found in this manner are prognostically significant, prospective trials now under way promise a definitive answer to this controversial subject. "Enhanced pathology using serial sections and immunohistochemical staining identifies a...
Source: Women's Health Weekly (2004-05-13)
|
